A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
Conditions
Hypercholesterolemia · Dyslipidemias · Primary Hypercholesterolemia · Heterozygous Familial Hypercholesterolemia · Hyperlipidemia; Mixed · Metabolic Disease · ASCVD
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beijing Anzhen Hospital of Capital Medical University, Beijing, Beijing Municipality, China
Beijing Luhe Hospital, Capital Medical Univeristy, Beijing, Beijing Municipality, China
Beijing Tsinghua Changgeng Hospital, Beijing, Beijing Municipality, China
Fuwai Hospital, CAMS & PUMC, Beijing, Beijing Municipality, China
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
Shijiazhuang People's Hospital, Shijiazhuang, Hebei, China
Daqingshi People's Hospital, Daqing, Heilingjiang, China
The 2nd Xiangya Hospital of Central South University, Changsha, Hunan, China
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Nanchang People's Hospital, Nanchang, Jiangxi, China
Binzhou Medical University Hospital, Binzhou, Shandong, China
Heze Municipal Hospital, Heze, Shandong, China
Qilu Hospital of Shandong University, Jinan, Shandong, China
Zibo Municipal Hospital, Zibo, Shandong, China
West China Hospital of Sichuan University, Chengdu, Sichuan, China
Tianjin People's Hospital, Tianjin, Tianjin Municipality, China
The First Affiliated Hospital of Wenzhou Medical Univesity, Wenzhou, Zhejiang, China
Peking University First Hospital, Beijing, China
Study leads
Yong Huo
Principal Investigator
Peking University First Hospital